Edition:
United States

La Jolla Pharmaceutical Co (LJPC.OQ)

LJPC.OQ on NASDAQ Stock Exchange Capital Market

12.80USD
14 Dec 2018
Change (% chg)

-- (--)
Prev Close
$12.80
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
148,471
52-wk High
$41.24
52-wk Low
$12.61

Chart for

About

La Jolla Pharmaceutical Company is a biopharmaceutical company. The Company is focused on the discovery, development and commercialization of therapies to improve outcomes in patients suffering from life-threatening diseases. LJPC-501 is its formulation of angiotensin II for the potential treatment of catecholamine-resistant... (more)

Overall

Beta: 1.39
Market Cap(Mil.): $401.11
Shares Outstanding(Mil.): 26.23
Dividend: --
Yield (%): --

Financials

  LJPC.OQ Industry Sector
P/E (TTM): -- 95.96 30.88
EPS (TTM): -7.91 -- --
ROI: -115.67 0.60 13.80
ROE: -212.22 -2.18 15.29

Earnings vs. Estimates